Introduction
Diuretics are essential agents in the management of hypertension, heart failure, edema, and renal conditions. They work by promoting the excretion of sodium and water, reducing blood volume and cardiac workload.
At Nirvana Pharma, we provide a complete portfolio of loop diuretics, thiazides, potassium-sparing agents, osmotic diuretics, and carbonic anhydrase inhibitors, ensuring comprehensive coverage for hospitals, clinics, and pharmacies.
📋 Diuretic Product Catalogue
Loop Diuretics
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Furosemide |
Loop (Na⁺-K⁺-2Cl⁻ blocker) |
Tab: 20, 40 mg; Inj: 10 mg/mL (2 mL, 4 mL amp) |
Edema, CHF, resistant HTN |
| Torsemide |
Loop |
Tab: 5, 10, 20, 40 mg |
CHF, HTN, edema |
| Bumetanide |
Loop |
Tab: 0.5, 1, 2 mg; Inj: 0.25 mg/mL |
Severe edema, CHF |
| Ethacrynic acid |
Loop (rare) |
Tab: 25 mg |
Edema (for sulfa allergy patients) |
Thiazide & Thiazide-like Diuretics
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Hydrochlorothiazide (HCTZ) |
Thiazide |
Tab: 12.5, 25, 50 mg |
HTN, mild edema |
| Chlorthalidone |
Thiazide-like |
Tab: 12.5, 25, 50 mg |
HTN, CHF |
| Indapamide |
Thiazide-like |
Tab: 1.25, 2.5 mg |
HTN, CHF |
| Metolazone |
Thiazide-like |
Tab: 2.5, 5, 10 mg |
Resistant edema, CHF |
Potassium-Sparing Diuretics
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Spironolactone |
Aldosterone antagonist |
Tab: 25, 50, 100 mg |
HTN, CHF, hyperaldosteronism, ascites |
| Eplerenone |
Selective aldosterone antagonist |
Tab: 25, 50 mg |
HTN, CHF |
| Amiloride |
ENaC blocker |
Tab: 5, 10 mg; Combo with HCTZ (5/50 mg) |
HTN, CHF, hypokalemia prevention |
| Triamterene |
ENaC blocker |
Cap: 50, 100 mg; Combo with HCTZ (37.5/25 mg) |
HTN, edema |
Osmotic Diuretics
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Mannitol |
Osmotic |
IV: 10%, 20% solution (100–250 mL bottles) |
Raised ICP, acute glaucoma, renal protection |
Carbonic Anhydrase Inhibitors
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Acetazolamide |
Systemic CAI |
Tab: 125, 250, 500 mg; IV: 500 mg vial |
Glaucoma, altitude sickness, metabolic alkalosis |
| Dorzolamide |
Topical CAI |
Ophthalmic soln: 2% |
Glaucoma |
| Brinzolamide |
Topical CAI |
Ophthalmic suspension: 1% |
Glaucoma |
Closing Note
Our diuretic portfolio ensures access to all major classes, from fast-acting loop diuretics to potassium-sparing agents and specialized ophthalmic carbonic anhydrase inhibitors. Nirvana Pharma delivers trusted quality, regulatory compliance, and timely supply for cardiovascular and renal care.
